Life Sciences
Accelerating drug discovery, clinical trials, and market access with AI and data-driven innovation
$1.6T
Global pharmaceutical market size
$2.6B
Average cost to bring a drug to market
10-15yrs
Traditional drug development timeline
50%
Reduction in discovery time using AI
The life sciences industry is at an inflection point — AI is dramatically accelerating drug discovery, real-world evidence is reshaping regulatory decisions, and digital health convergence is creating new business models. Luminatech partners with pharmaceutical companies, biotech firms, CROs, and medical device companies to build intelligent research platforms, accelerate clinical operations, and optimize commercial strategies.
What's Holding the Industry Back
Drug Discovery Productivity Crisis
Despite massive R&D investment, drug attrition rates remain above 90%. Traditional molecule screening approaches are too slow and expensive to explore the vast chemical space efficiently.
Clinical Trial Inefficiency
Clinical trials consume 40-60% of R&D budgets, yet 80% fail to enroll on time and 30% of sites underperform. Patient recruitment, protocol complexity, and data management challenges drive delays and cost overruns.
Real-World Data Utilization
Enormous volumes of EHR data, claims data, and patient registries remain underutilized for regulatory submissions, post-market surveillance, and health economics research.
Market Access & Pricing Complexity
Demonstrating value to payers, navigating diverse reimbursement landscapes, and supporting patient access programs across global markets requires sophisticated analytics and economic modeling capabilities.
Luminatech Solutions for Life Sciences
AI Drug Discovery Platform
Generative AI and deep learning models for molecular property prediction, hit identification, lead optimization, and ADMET prediction — dramatically reducing the time and cost of early-stage drug discovery.
Intelligent Clinical Trial Operations
AI-powered patient recruitment, site feasibility scoring, risk-based monitoring, and clinical data analytics platforms that accelerate trial execution and improve data quality.
Real-World Evidence Platform
FHIR-compliant real-world data platforms integrating EHR, claims, registry, and wearable data for regulatory-grade RWE studies, safety surveillance, and health economics outcomes research.
Commercial Analytics & Market Access
Integrated commercial analytics platforms covering market access modeling, payer landscape analysis, HCP targeting, and patient journey analytics to optimize launch strategies and access programs.
Relevant Luminatech Services
Client Success Stories
AI-Powered Target Identification
Implemented a graph neural network platform for a mid-size biotech analyzing protein interaction networks and genomic data across 50 disease indications. Identified 3 novel therapeutic targets in 6 months that would have taken 2+ years using traditional approaches.
Clinical Trial Patient Matching
Built an AI patient recruitment platform for a global CRO that screens EHR data across a network of 2,000 sites to identify trial-eligible patients. Time to enrollment milestones improved by 55%, and screen failure rates dropped by 38%.
Real-World Evidence for Label Expansion
Developed a real-world evidence study platform using 4.5M patient records to demonstrate comparative effectiveness for a biologic drug's label expansion. The FDA accepted the RWE submission, eliminating the need for an additional Phase 3 trial — saving $380M.
Frequently Asked Questions
Ready to transform your Life Sciences operations?
Talk to our Life Sciences specialists and get a tailored solution roadmap.